NASDAQ:PTGX (Protagonist Therapeutics)

About PTGX

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. The Company operates and manages its business as one operating segment.
  • Protagonist Therapeutics (NASDAQ: PTGX) Latest News

    No posts found.